{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-21-061610","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2021-11-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.515850+00:00","generated_at":"2026-06-28T05:40:01.538454+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"China Pharma raises $5M via convertible note to Streeterville Capital with 5% interest and 15-month maturity","bullets":["Issued unsecured convertible promissory note for $5.25M principal ($5M net proceeds after $250K OID) to Streeterville Capital.","Note carries 5% annual interest; upon default, interest rises to 22% and balance accelerates with 15% or 5% penalty.","Company reserved 30M common shares for conversion; conversion price at 85% of lowest 10-day VWAP during prior 10 trading days.","Proceeds used for general working capital; Streeterville's consent required for fundamental transactions.","Company must file prospectus supplement within 30 days to register up to $5M of common stock for investor."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-21-061610","json":"https://secwatch.observer/filing/0001213900-21-061610.json","markdown":"https://secwatch.observer/filing/0001213900-21-061610.md","text":"https://secwatch.observer/filing/0001213900-21-061610.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390021061610/0001213900-21-061610-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390021061610/ea151262-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:40:01.538454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}